Scientific deep-dive

Mounjaro and Constipation: Why It Happens & How to Get Relief (2026)

Constipation is a labeled, common side effect of Mounjaro (tirzepatide). Why it happens, prescriber-directed relief, red flags like ileus, and how it eases as your body adjusts.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7 min read·5 citations

Yes — constipation is a common side effect of Mounjaro, and it is well enough recognized that constipation is listed as an adverse reaction in the tirzepatide prescribing information, appearing in the §6 Adverse Reactions sections of both the Mounjaro and the Zepbound labels at single-digit to low-double-digit rates that rise with dose.[1][2] The reason is built into how the drug works: Mounjaro is tirzepatide, a dual GIP and GLP-1 receptor agonist (the same molecule sold as Zepbound for weight management), and a core part of how it curbs appetite is by slowing gastric emptying and gut motility — so food and stool move through more slowly.[4] On top of that, the sharp appetite drop means many people eat and drink less while on it, which usually means less fiber and less fluid — and low fiber, low fluid, and slow transit together firm and slow the stool. This guide explains why it happens, the practical and prescriber-directed steps that bring relief, the red flags that mean you should stop and seek care, and why it usually eases as your body adjusts. See our Mounjaro drug page for the full picture, and our companion guide on constipation on semaglutide for the closely related GLP-1 single-agonist drugs. This is general educational information, not medical advice — your prescriber manages your care.

About this article

Every claim below about whether constipation is a labeled side effect was verified against the FDA prescribing information on DailyMed (NIH) — the §6 "Adverse Reactions" sections of the Mounjaro and Zepbound (tirzepatide) labels — not an AI paraphrase or a third-party drug-monograph site. The mechanism we describe — that tirzepatide slows gastric emptying and gastrointestinal motility — is documented in the peer-reviewed literature on incretin (GIP/GLP-1) effects on gut physiology. Reported rates vary by dose, by trial population, and by whether tirzepatide is taken with other medications, so treat any figures as approximate. For the closely related semaglutide drugs see our constipation on semaglutide guide, and for the full drug overview the Mounjaro drug page. This is general information, not medical advice — your prescriber individualizes your care.

Is constipation a Mounjaro side effect?

Yes. Constipation is a labeled adverse reaction for tirzepatide. It appears in the §6 Adverse Reactions sections of both the Mounjaro (tirzepatide for type 2 diabetes) and the Zepbound (tirzepatide for chronic weight management) prescribing information, reported more often than with placebo.[1][2] The reported frequency generally sits in the single-digit to low-double-digit percentage range and is dose-dependent — like the other gastrointestinal effects, constipation tends to be more common at higher doses and during the dose-escalation weeks.[2] Because Mounjaro and Zepbound are the same molecule, the same mechanism applies across both; the main difference is the approved use and the dose.

Constipation sits alongside the other well-known gastrointestinal effects — nausea, vomiting, and diarrhea — and is part of the same package of gut effects that tirzepatide produces.[4] It is worth knowing that some people experience the opposite problem (diarrhea) instead, and a few swing between the two; both stem from the way tirzepatide alters how the gut moves. The MedlinePlus consumer summary for tirzepatide lists constipation among the common side effects and reminds patients to tell their prescriber if a side effect is severe or does not go away.[3]

Why Mounjaro causes constipation

Constipation on Mounjaro is not a random or mysterious effect — it is a fairly direct consequence of how the drug works, layered with a couple of behavioral knock-on effects. There are three main threads, and most people who get constipated have all three working together:

  • Slowed gastric emptying and gut motility. Tirzepatide is a dual GIP and GLP-1 receptor agonist, and a core part of how it curbs appetite is by slowing the rate at which the stomach empties and dampening the muscular contractions that move contents through the gut. The same braking action that keeps you feeling full longer also moves stool through the colon more slowly — and the longer stool sits in the colon, the more water is reabsorbed from it, making it harder and drier.[4]
  • Eating less — so less fiber. Mounjaro works largely by suppressing appetite, so most people eat noticeably less while on it. Eating less very often means less dietary fiber, and fiber is what gives stool bulk and softness and helps it move; a low-fiber intake is one of the most common everyday causes of constipation.
  • Drinking less — so less fluid. With appetite and thirst cues blunted, fluid intake often falls too. Low fluid intake compounds the problem: when there is less water available and stool is already sitting longer in the colon, it becomes firmer and harder to pass. Any nausea that reduces drinking makes this worse.

Put together, you have slower transit (more time for water to be pulled out of stool), less fiber (less bulk), and less fluid (less water in) — a combination almost engineered to firm and slow the stool. The good news is that two of those three threads are behavioral and addressable, which is why the relief strategies below tend to work well when applied consistently.

Why Mounjaro (tirzepatide) leads to constipation — the contributing factor, what's happening, and what generally helps. All management is prescriber-directed; do not change your dose or start a laxative regimen on your own. The drug's labeled status is verified against the FDA DailyMed Mounjaro and Zepbound labels.
Contributing factorWhat's happeningWhat generally helps
Slowed gastric emptying & gut motilityTirzepatide slows the stomach and colon; stool sits longer, so more water is reabsorbed and it firms upGentle physical activity to stimulate the gut; ask your prescriber about an osmotic laxative or stool softener if needed
Lower fiber intakeAppetite suppression means eating less, which usually means less stool-bulking fiberIncrease soluble fiber gradually, always with enough water; a fiber supplement only if your prescriber agrees
Lower fluid intakeBlunted thirst and nausea can cut fluid intake, leaving stool firmer and harder to passDrink steadily through the day; pair every fiber increase with more water, not less
Dose-escalation weeksGI side effects, including constipation, can be more pronounced after each dose step-up before easingYour prescriber can hold the current dose longer before stepping up; slower titration is allowed

How to get relief from Mounjaro constipation

Because the constipation traces back to slow transit, low fiber, and low fluid, the fixes target those drivers — and most people respond well to a few consistent habits. The following are general, commonly-discussed strategies, but all of them are prescriber-directed: do not start a laxative or stool softener, add a magnesium supplement, or change your Mounjaro dose without talking to your clinician, especially if you have kidney, heart, or other medical conditions.

  • Stay well hydrated. Drink fluids steadily through the day rather than relying on thirst, which can be blunted on Mounjaro. Adequate water is the single most important and lowest-risk step, and it is what makes a fiber increase actually work instead of backfiring.
  • Increase soluble fiber — gradually, and with water. Foods rich in soluble fiber (oats, beans, lentils, fruits, vegetables, psyllium) add bulk and softness to stool. Ramp up slowly to avoid gas and bloating, and always pair more fiber with more fluid; adding fiber without enough water can make constipation worse, not better.
  • Move your body. Regular physical activity — even a daily walk — helps stimulate gut motility and is one of the simplest counters to the slowed transit tirzepatide causes.
  • Ask your prescriber about an osmotic laxative or stool softener. If diet, fluids, and activity aren't enough, clinicians often suggest an osmotic laxative such as polyethylene glycol or a stool softener — but only if your prescriber okays it, since the right choice and duration depend on your health. These pull or keep water in the stool to soften it.
  • Discuss magnesium with your clinician. Some people ask about magnesium (for example magnesium-containing products that have a mild osmotic effect). Whether it's appropriate — and at what form and amount — is a conversation for your prescriber or pharmacist, not a self-prescribed default, particularly if you have any kidney issues.
  • Don't strain, and don't ignore the urge. Straining can cause hemorrhoids and other problems; respond to the urge when it comes rather than putting it off, since holding stool gives the colon more time to dry it out.
  • Mind the titration. GI side effects often cluster just after a dose increase. Your prescriber can hold you at the current dose longer before stepping up if a rung is rough; slower dose escalation is allowed and is the label's intended response to poor tolerability, and it reduces GI side effects overall.[1]

If your symptom is actually the opposite — loose or frequent stools — the same slow-the-titration and hydration principles apply, but the food and fluid advice differs, so flag which direction you're dealing with when you talk to your prescriber. For how this compares on the GLP-1 single-agonist drugs, see our guide to constipation on semaglutide.

When Mounjaro constipation is a red flag

Most constipation on Mounjaro is the ordinary, manageable kind — uncomfortable but not dangerous, and responsive to the steps above. But because the drug slows the gut, it is worth knowing the warning signs that mean constipation has crossed into something that needs prompt medical attention. Stop and seek care — call your prescriber or seek urgent/emergency care depending on severity — for any of the following:

  • Severe or worsening abdominal pain, especially if it is constant rather than crampy and comes with a hard, distended belly.
  • No bowel movement for several days together with bloating and vomiting, or an inability to pass gas — this combination can signal a bowel obstruction or ileus (the gut effectively stalling), which is a medical emergency.
  • Blood in the stool, black or tarry stools, or rectal bleeding — these always warrant evaluation rather than waiting it out.
  • Persistent constipation that does not improve with hydration, fiber, activity, and the measures your prescriber has advised, or constipation severe enough to disrupt daily life.[3]

A note on ileus

Because GIP/GLP-1 receptor agonists slow gastrointestinal motility, a rare signal of ileus — a stalling of the gut's normal forward movement — has been noted in post-marketing reports for this incretin drug class. It is uncommon, but it is the reason the red flags above matter: severe abdominal pain, no bowel movement for several days with bloating and vomiting, or an inability to pass gas should prompt urgent medical evaluation rather than another dose of laxative. When in doubt, contact your prescriber or seek care.

Does Mounjaro constipation go away?

For most people, it improves as the body adjusts. Like the other gastrointestinal effects, constipation tends to be most pronounced in the first weeks and right after each dose increase, then ease over the following weeks as the gut adapts to the slower transit and as you settle into steady hydration and fiber habits.[4] Reaching a stable maintenance dose — the titration plateau — usually coincides with the symptoms calming down, and the relief strategies above accelerate that.

What is not the typical pattern is constipation that is severe, accompanied by significant abdominal pain or vomiting, or simply not improving despite consistent hydration, fiber, activity, and any measures your prescriber recommended. That kind warrants a conversation with your prescriber, who can rule out anything serious and adjust the plan. If you are choosing where to start or continue tirzepatide under proper supervision, see the Mounjaro drug page. A legitimate provider titrates you on the label schedule and follows up on side effects like constipation — exactly the monitoring that keeps the experience manageable.

References

  1. 1.Eli Lilly and Company MOUNJARO (tirzepatide) injection, for subcutaneous use — US Prescribing Information, §6 Adverse Reactions (constipation among reported gastrointestinal reactions) and §2 dose-escalation schedule. DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  2. 2.Eli Lilly and Company ZEPBOUND (tirzepatide) injection, for subcutaneous use — US Prescribing Information, §6 Adverse Reactions, including constipation reported for chronic weight management, and the stepwise dose-escalation schedule. DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  3. 3.U.S. National Library of Medicine (MedlinePlus) Tirzepatide Injection — consumer drug information, including common side effects such as constipation and guidance to contact a prescriber if a side effect is severe or does not go away. MedlinePlus (NIH). 2025. https://medlineplus.gov/druginfo/meds/a622044.html
  4. 4.Maselli DB, Camilleri M Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity — review documenting that incretin receptor agonists slow gastric emptying and gastrointestinal motility. Adv Exp Med Biol. 2021. https://pubmed.ncbi.nlm.nih.gov/32077010/
  5. 5.France NL, Syed YY Tirzepatide: A Review in Type 2 Diabetes — review of the dual GIP/GLP-1 receptor agonist, including its gastrointestinal tolerability profile across the SURPASS program. Drugs. 2024. https://pubmed.ncbi.nlm.nih.gov/38388874/

Where to get tirzepatide (Mounjaro / Zepbound): vetted providers

Vetted telehealth providers that prescribe online, ranked by our editorial score. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.9

Get Thin MD

Lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available

7.8

Gala

Compounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwide

7.7

MyStart Health

Fastest compounded GLP-1 onboarding with a price lock